Slate Run Pharmaceuticals recalls

Slate Run Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 4 Mar 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls3since 2025

Last 12 months1reported

Class I00% of total

Ongoing1latest 4 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 2 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 1 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why slate run pharmaceuticals is recalled

Nitrosamine Impurity267%
Other Reasons133%

Product types

Injectable & IV Drugs133%

By year

2026133%
2025267%

Ongoing slate run pharmaceuticals recalls

1 active

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS III	Eptifibatide Injection, 75 mg/ vial recalledEptifibatide	Slate Run Pharmaceuticals	Other	Nationwide

All slate run pharmaceuticals recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
4 Mar 2026Drug	CLASS III	Eptifibatide Injection, 75 mg/ vial recalledEptifibatide	Slate Run Pharmaceuticals	Other	Nationwide
26 Mar 2025Drug	CLASS II	Cinacalcet Hydrochloride Tablets 30 mg recalled	Slate Run Pharmaceuticals	Nitrosamine Impurity	Nationwide
26 Mar 2025Drug	CLASS II	Cinacalcet Hydrochloride Tablets 60 mg recalled	Slate Run Pharmaceuticals	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.